March 20, 2020 / 8:50 PM / 12 days ago

BRIEF-Amneal Accelerates Production Of Hydroxychloroquine Sulfate

March 20 (Reuters) - Amneal Pharmaceuticals Inc:

* AMNEAL ACCELERATES DISTRIBUTION AND PRODUCTION OF HYDROXYCHLOROQUINE SULFATE TO MEET POTENTIAL NEEDS OF COVID-19 PATIENTS NATIONWIDE

* AMNEAL PHARMACEUTICALS - RAMPING UP PRODUCTION OF HYDROXYCHLOROQUINE SULFATE & EXPECTS TO PRODUCE ABOUT 20 MILLION TABLETS BETWEEN NOW & MID-APRIL

* AMNEAL PHARMA - CO’S HYDROXYCHLOROQUINE SULFATE TABLETS APPROVED BY FDA TO TREAT MALARIA, RHEUMATOID ARTHRITIS, LUPUS, CHILDHOOD ARTHRITIS, OTHERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below